Baxter Units Face IP Suit Over Actifuse Bone Graft Product

Law360, New York (April 24, 2013, 8:54 PM EDT) -- Two Baxter International Inc. units were hit with a lawsuit Wednesday by Millenium Biologix LLC that accused the Deerfield, Ill.-based medical device giant’s units of infringing its patents by selling the bone void filler product Actifuse bone graft substitute.

In a complaint filed in Illinois federal court, Millenium claimed Baxter Healthcare Corp. and ApaTech Inc. violated two of its patents by selling the Actifuse bone void filler product, which is meant for orthopedic treatments to strengthen bone structure. Millenium claimed the product infringed two related patents including...
To view the full article, register now.